Stay updated on Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a new Study Status entry on 2026-04-03 for revision v3.5.2. Removed the older v3.5.0 revision on 2026-03-02.
    Difference
    0.4%
    Check dated 2026-04-16T10:31:00.000Z thumbnail image
  2. Check
    21 days ago
    No Change Detected
  3. Check
    28 days ago
    Change Detected
    Summary
    A new revision entry v3.5.0 was added to the history. The previous revision v3.4.3 was removed from the list.
    Difference
    0.1%
    Check dated 2026-03-25T20:33:59.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision log updated to v3.4.3, replacing the previous v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T14:51:46.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    The Record History page now includes a Study Status section with new entries on 2026-02-27 and 2026-03-02. The 2026-01-26 entry was removed.
    Difference
    0.3%
    Check dated 2026-03-04T09:11:23.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Version history shows a new Revision: v3.4.2 added, and the funding-status notice along with Revision: v3.4.1 removed. These changes are limited to system-wide versioning and notices and do not modify study data or record content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T02:07:37.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Added a site-wide notice about potential data delays due to government funding issues and updated the page version to v3.4.1. Removed the previous v3.4.0.
    Difference
    0.6%
    Check dated 2026-02-03T23:48:05.000Z thumbnail image

Stay in the know with updates to Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide and Daratumumab in High-Risk Smoldering Myeloma Clinical Trial page.